● Recruiting

Single-ascending Dose Study of HEC-151 Injection

Condition: Healthy Adult Male · Sponsor: Sunshine Lake Pharma Co., Ltd.

PhasePhase 1

Planned participants81

Who can joinMale, 18 Years to 45 Years

Healthy volunteersYes

About this study

Evaluate the safety, tolerability, PK/PD and immunogenicity characteristics of a single subcutaneous HEC-151 Injection solution in healthy participants

This description comes directly from the study's public registry record.

Talk to the study team

Chengyong Tang, Doctor · +8618983286980 · 17235387@qq.com

Always discuss trial participation with your own doctor first.

Locations (2)

No. 9, Shuangxing Avenue,, Bishan	Chongqing, Bishan, China	Recruiting
No. 9, Shuangxing Avenue,	Bishan, Chongqing Municipality, China	Not Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07376200